Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Active not recruiting 2Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma, Follicular 6Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma 3Lymphoma, Large B-Cell, Diffuse 2Leukemia, Lymphocytic, Chronic, B-Cell 2Neoplasms 1Lymphoma, B-Cell 1

Interventions

Cyclophosphamide 13Rituximab 11obinutuzumab 6fludarabine phosphate 6Prednisone 6Magnetic Resonance Spectroscopy 6ibrutinib 5fludarabine 5X-Rays 5Specimen Handling 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 5Melphalan 5Lenalidomide 5Etoposide 5Doxorubicin 5Biopsy 5tocilizumab 4Whole-Body Irradiation 4venetoclax 3polatuzumab vedotin 3glofitamab 3acalabrutinib 3Vincristine 3Mycophenolic Acid 3Leukapheresis 3Filgrastim 3Cytarabine 3Cyclosporine 3Busulfan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Lymphoma, Non-Hodgkin × Bendamustine Hydrochloride × 30 days × Clear all
NCT06191744 2026-06-02

EPCOREâ„¢FL-2

Genmab

Phase 3 Recruiting
1,095 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms

NCT02972840 2026-06-01

A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL

Acerta Pharma BV

Phase 3 Active not recruiting
635 enrolled 1 FDA
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

NCT04002297 2026-05-18

MANGROVE

BeOne Medicines

Phase 3 Active not recruiting
510 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡